Skip to main content
. 2024 Feb 29;70:102516. doi: 10.1016/j.eclinm.2024.102516

Fig. 3.

Fig. 3

Pharmacokinetics of RJMty19. CAR-DNT cell kinetics were assessed by flow cytometry (A) and quantitative PCR (B) at different timepoints. Higher proportions of CAR+ cells in CD3+ T cells were seen in patients who received higher doses of CAR-DNT cell therapy (C). Note: Data are median (IQR) or No (%), DL, Dose Level.